Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Target-seeking cancer treatment works

07.02.2006


Treatment with target-seeking antibodies reduces growth in certain tumor cells and does so in a different way than with ordinary radiation therapy. This is shown by David Eriksson in a new dissertation at Umeå University in Sweden.



Tumor diseases can be treated with surgery, radiation, or chemotherapy. A new type of treatment that makes use of the antibodies with radioactive substances attached has attracted more and more interest. When the antibodies are injected they have the capacity to wander around in the blood circulation and actively attract tumors to them. In other words, they are target-seeking antibodies. They can even find tumors that have not grown large enough to be detected by other methods. When the antibody binds to the tumor, the radioactive substance can deliver local radiation for a long time.

The dissertation shows that this type of cancer treatment, “radioimmune therapy,” can provide substantial inhibition of tumor cell growth. However, the operative mechanism is not the same as in ordinary radiation treatment. In this case the low-dose radiation is emitted over a long period and activates parts of the cell’s defense system, which makes cells temporarily stop dividing in order to repair any damage from the radiation. If this doesn’t succeed, then the cells will try to multiply with damaged genes, which results in “cell division disasters” and ultimate activation of the “suicide programs” that make the tumor cells die of their own accord. These new methods of treatment are seen as having great potential and have already been put to use for certain tumor diseases.

Hans Fällman | alfa
Further information:
http://www.umu.se

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Researchers release the brakes on the immune system

18.10.2017 | Health and Medicine

Separating methane and CO2 will become more efficient

18.10.2017 | Life Sciences

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>